Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 607271, 11 pages
http://dx.doi.org/10.1155/2015/607271
Research Article

A Novel Antioxidant Multitarget Iron Chelator M30 Protects Hepatocytes against Ethanol-Induced Injury

1National Key Disciplines for Infectious Diseases, Shenzhen Third People’s Hospital, Shenzhen 518112, China
2Department of Immunobiology, Institute of Tissue Transplantation and Immunology, Jinan University, Guangzhou 510632, China
3Department of Anatomy, The University of Hong Kong, Pokfulam, Hong Kong
4Eve Topf Centers of Excellence, Technion, Rappaport Family Faculty of Medicine and Department of Pharmacology, 31096 Haifa, Israel

Received 13 October 2014; Accepted 14 January 2015

Academic Editor: Vittorio Calabrese

Copyright © 2015 Jia Xiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Global Status Report on Alcohol and Health, World Health Organization, Geneva, Switzerland, 2011.
  2. S. Bellentani, G. Saccoccio, G. Costa et al., “Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group,” Gut, vol. 41, no. 6, pp. 845–858, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. M. M. Jaurigue and M. S. Cappell, “Therapy for alcoholic liver disease,” World Journal of Gastroenterology, vol. 20, no. 9, pp. 2143–2158, 2014. View at Publisher · View at Google Scholar
  4. B. Gao and R. Bataller, “Alcoholic liver disease: pathogenesis and new therapeutic targets,” Gastroenterology, vol. 141, no. 5, pp. 1572–1585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Dey and A. I. Cederbaum, “Alcohol and oxidative liver injury,” Hepatology, vol. 43, no. 2, supplement 1, pp. S63–S74, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. L. Fink and B. T. Cookson, “Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells,” Infection and Immunity, vol. 73, no. 4, pp. 1907–1916, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Xiao, Y. Zhu, Y. Liu, G. L. Tipoe, F. Xing, and K.-F. So, “Lycium barbarum polysaccharide attenuates alcoholic cellular injury through TXNIP-NLRP3 inflammasome pathway,” International Journal of Biological Macromolecules, vol. 69, pp. 73–78, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. G. L. Semenza, “Hypoxia-inducible factors in physiology and medicine,” Cell, vol. 148, no. 3, pp. 399–408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Majmundar, W. J. Wong, and M. C. Simon, “Hypoxia-inducible factors and the response to hypoxic stress,” Molecular Cell, vol. 40, no. 2, pp. 294–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Ouyang, A. Ghani, A. Malik et al., “Adenosine is required for sustained inflammasome activation via the A2A receptor and the HIF-1α pathway,” Nature Communications, vol. 4, article 2909, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Wang, D. Wu, L. Yang, L. Gan, and A. I. Cederbaum, “Cyto chrome P450 2E1 potentiates ethanol induction of hypoxia and HIF-1α in vivo,” Free Radical Biology and Medicine, vol. 63, pp. 175–186, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Zheng, L. M. Weiner, O. Bar-Am et al., “Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases,” Bioorganic and Medicinal Chemistry, vol. 13, no. 3, pp. 773–783, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Zheng, S. Gal, L. M. Weiner et al., “Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition,” Journal of Neurochemistry, vol. 95, no. 1, pp. 68–78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Xiao, Z.-C. Zhou, C. Chen et al., “Tumor necrosis factor-alpha gene from mandarin fish, Siniperca chuatsi: molecular cloning, cytotoxicity analysis and expression profile,” Molecular Immunology, vol. 44, no. 14, pp. 3615–3622, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Xiao, F. Xing, J. Huo et al., “Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model,” Scientific Reports, vol. 4, article 5587, 2014. View at Publisher · View at Google Scholar
  16. S. A. Bustin, V. Benes, J. A. Garson et al., “The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments,” Clinical Chemistry, vol. 55, no. 4, pp. 611–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Xiao, Y. P. Ching, E. C. Liong, A. A. Nanji, M. L. Fung, and G. L. Tipoe, “Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model,” European Journal of Nutrition, vol. 52, no. 1, pp. 179–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Avramovich-Tirosh, T. Amit, O. Bar-Am, H. Zheng, M. Fridkin, and M. B. H. Youdim, “Therapeutic targets and potential of the novel brain-permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease,” Journal of Neurochemistry, vol. 100, no. 2, pp. 490–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Kupershmidt, O. Weinreb, T. Amit, S. Mandel, M. T. Carri, and M. B. H. Youdim, “Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis,” The FASEB Journal, vol. 23, no. 11, pp. 3766–3779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. B. Owen and D. A. Butterfield, “Measurement of oxidized/reduced glutathione ratio,” Methods in Molecular Biology, vol. 648, pp. 269–277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. H. J. Wang, B. Gao, S. Zakhari, and L. E. Nagy, “Inflammation in alcoholic liver disease,” Annual Review of Nutrition, vol. 32, pp. 343–368, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Kakiyama, P. B. Hylemon, H. Zhou et al., “Colonic inflammation and secondary bile acids in alcoholic cirrhosis,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 306, no. 11, pp. G929–G937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Peng, B. A. French, B. Tillman et al., “The inflammasome in alcoholic hepatitis: its relationship with Mallory-Denk body formation,” Experimental and Molecular Pathology, vol. 97, no. 2, pp. 305–313, 2014. View at Publisher · View at Google Scholar
  24. W. Zhang, J.-M. Petrovic, D. Callaghan et al., “Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1β (IL-1β) in astrocyte cultures,” Journal of Neuroimmunology, vol. 174, no. 1-2, pp. 63–73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Kvietikova, R. H. Wenger, H. H. Marti, and M. Gassmann, “The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site,” Nucleic Acids Research, vol. 23, no. 22, pp. 4542–4550, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Mandal, V. K. Nelson, S. Mukhopadhyay et al., “14-Deoxyandrographolide targets adenylate cyclase and prevents ethanol-induced liver injury through constitutive NOS dependent reduced redox signaling in rats,” Food and Chemical Toxicology, vol. 59, pp. 236–248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Mechlovich, T. Amit, O. Bar-Am, O. Weinreb, and M. B. H. Youdim, “Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus,” The British Journal of Pharmacology, vol. 171, no. 24, pp. 5636–5649, 2014. View at Publisher · View at Google Scholar
  28. E. Sofic, M. Salkovic-Petrisic, I. Tahirovic et al., “Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30,” Journal of Neural Transmission, 2014. View at Publisher · View at Google Scholar
  29. M. B. H. Youdim, L. Kupershmidt, T. Amit, and O. Weinreb, “Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease,” Parkinsonism and Related Disorders, vol. 20, supplement 1, pp. S132–S136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Johnson, S. Tazik, and D. Lu, “The new inhibitor of monoamine oxidase, M30, has a neuroprotective effect against dexamethasone-induced brain cell apoptosis,” Frontiers in Neuroscience, vol. 4, article 180, 2010. View at Google Scholar
  31. B. Nath, I. Levin, T. Csak et al., “Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice,” Hepatology, vol. 53, no. 5, pp. 1526–1537, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. E. J. Folco, G. K. Sukhova, T. Quillard, and P. Libby, “Moderate hypoxia potentiates interleukin-1β production in activated human macrophages,” Circulation Research, vol. 115, no. 10, pp. 875–883, 2014. View at Publisher · View at Google Scholar
  33. D. Shaikh, Q. Zhou, T. Chen, J. C. F. Ibe, J. U. Raj, and G. Zhou, “CAMP-dependent protein kinase is essential for hypoxia-mediated epithelial-mesenchymal transition, migration, and invasion in lung cancer cells,” Cellular Signalling, vol. 24, no. 12, pp. 2396–2406, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Van de Velde, M. F. Hogan, and M. Montminy, “mTOR links incretin signaling to HIF induction in pancreatic beta cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 41, pp. 16876–16882, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Yang, Z. Wang, Y. Zhan et al., “Endogenous A1 adenosine receptor protects mice from acute ethanol-induced hepatotoxicity,” Toxicology, vol. 309, pp. 100–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. D. J. Chiang, S. Roychowdhury, K. Bush et al., “Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis,” PLoS ONE, vol. 8, no. 7, Article ID e69114, 2013. View at Publisher · View at Google Scholar · View at Scopus